The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)
Official Title: A Multicenter Randomized Phase II Trial in NSCLC Stage IV et IIIB in Elderly Dependent Patients With Evaluation of the Sequence Gemcitabine First Line Followed by Erlotinib When Progression Versus Erlotinib First Line Followed by Gemcitabine When Progression.
Study ID: NCT00419042
Brief Summary: The purpose of this study is in non small-cell lung cancer stage IV et IIIB (T4 with pleural effusion) in elderly dependent patients with evaluation of the sequence Gemcitabine first line followed by Erlotinib when progression versus Erlotinib first line followed by Gemcitabine when progression
Detailed Description: A multicenter phase II trial,prospective,randomized,open,non comparative
Minimum Age: 65 Years
Eligible Ages: OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Site 12, Aix En Provence, , France
Site 05, Bastia, , France
Site 22, Beauvais, , France
Site 43, Caen, , France
Site 30, Charleville Mezieres, , France
Site 33, Creteil, , France
Site 07, Draguignan, , France
Site 32, Elbeuf, , France
Site 04, GAP, , France
Site 41, Le Chesnay, , France
Site 00, Limoges, , France
Site 25, Mantes La Jolie, , France
Site 06, Marseille, , France
Site 27, Martigues, , France
Site 01, Meaux, , France
Site 42, Orleans, , France
Site 26, Paris, , France
Site 19, Perigueux, , France
Site 02, Reims, , France
Site 20, Rennes, , France
Site 17, Rouen, , France
Site 14, Toulon, , France
Site 11, Villefranche Sur Saone, , France
Name: Hervé LECAER, Doctor
Affiliation: Groupe Francais De Pneumo-Cancerologie
Role: PRINCIPAL_INVESTIGATOR